OC04.06: A comparison of the homologous recombination deficiency test success rate using samples from ultrasound‐guided biopsies and those obtained during laparotomies in advanced ovarian cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      This article discusses a study that aimed to identify factors that influence the success rate and time-to-result of testing for tumour homologous recombination deficiency (HRD) in patients with advanced high-grade epithelial ovarian cancer. The study found that samples taken during surgery had a higher test success rate compared to those obtained using ultrasound-guided biopsy. Additionally, diagnostic biopsies taken with a larger needle gauge resulted in greater rates of test success. The article concludes that by optimizing HRD testing, treatment can be optimized at the earliest possible timepoint. [Extracted from the article]
    • Abstract:
      Copyright of Ultrasound in Obstetrics & Gynecology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)